Literature DB >> 11278490

The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway.

B Hu1, X Y Zhou, X Wang, Z C Zeng, G Iliakis, Y Wang.   

Abstract

Checkpoints respond to DNA damage by arresting the cell cycle to provide time for facilitating repair. In mammalian cells, the G(2) checkpoint prevents the Cdc25C phosphatase from removing inhibitory phosphate groups from the mitosis-promoting kinase Cdc2. Both Chk1 and Chk2, the checkpoint kinases, can phosphorylate Cdc25C and inactivate its in vitro phosphatase activity. Therefore, both Chk1 and Chk2 are thought to regulate the activation of the G(2) checkpoint. Here we report that A1-5, a transformed rat embryo fibroblast cell line, shows much more radioresistance associated with a much stronger G(2) arrest response when compared with its counterpart, B4, although A1-5 and B4 cells have a similar capacity for nonhomologous end-joining DNA repair. These phenotypes of A1-5 cells are accompanied by a higher Chk1 expression and a higher phosphorylation of Cdc2. On the other hand, Chk2 expression increases slightly following radiation; however, it has no difference between A1-5 and B4 cells. Caffeine or UCN-01 abolishes the extreme radioresistance with the strong G(2) arrest and at the same time reduces the phosphorylation of Cdc2 in A1-5 cells. In addition, Chk1 but not Chk2 antisense oligonucleotide sensitizes A1-5 cells to radiation-induced killing and reduces the G(2) arrest of the cells. Taken together these results suggest that the Chk1/Cdc25C/Cdc2 pathway is the major player for the radioresistance with G(2) arrest in A1-5 cells.

Entities:  

Keywords:  NASA Discipline Radiation Health; Non-NASA Center

Mesh:

Substances:

Year:  2001        PMID: 11278490     DOI: 10.1074/jbc.M009340200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.

Authors:  Meredith A Morgan; Leslie A Parsels; Lili Zhao; Joshua D Parsels; Mary A Davis; Maria C Hassan; Sankari Arumugarajah; Linda Hylander-Gans; Deborah Morosini; Diane M Simeone; Christine E Canman; Daniel P Normolle; Sonya D Zabludoff; Jonathan Maybaum; Theodore S Lawrence
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Cell cycle and radiosensitivity of progeny of irradiated primary cultured human hepatocarcinoma cells.

Authors:  Zhi-Zhong Liu; Wen-Ying Huang; Ju-Sheng Lin; Xiao-Sheng Li; Kuo-Huan Liang; Jia-Long Huang
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Apoptotic sensitivity to irradiation increased after transfection of chk1 antisense chain to HL-60 cell line.

Authors:  Yi Tang; Wenli Liu; Jianfeng Zhou; Qinglei Gao; Jianhong Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 4.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

5.  MicroRNA-376a sensitizes cells following DNA damage by downregulating MEPE expression.

Authors:  Jipo Sheng; Wei Luo; Fang Yu; Ning Gao; Baocheng Hu
Journal:  Cancer Biother Radiopharm       Date:  2013-04-09       Impact factor: 3.099

6.  A small peptide mimicking the key domain of MEPE/OF45 interacting with CHK1 protects human cells from radiation-induced killing.

Authors:  Xiaoyan Yu; Hongyan Wang; Shuang Liu; Xiangming Zhang; Peter Guida; Baocheng Hu; Ya Wang
Journal:  Cell Cycle       Date:  2010-05-15       Impact factor: 4.534

Review 7.  Targeting the checkpoint kinase Chk1 in cancer therapy.

Authors:  Callie Merry; Kang Fu; Jingna Wang; I-Ju Yeh; Youwei Zhang
Journal:  Cell Cycle       Date:  2010-01-27       Impact factor: 4.534

8.  DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.

Authors:  Zhao-Chong Zeng; Guo-Liang Jiang; Guo-Min Wang; Zhao-You Tang; Walter J Curran; George Iliakis
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

9.  MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers.

Authors:  P Zhang; H Wang; P S N Rowe; B Hu; Y Wang
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1.

Authors:  Shuang Liu; Hongyan Wang; Xiang Wang; Lin Lu; Ning Gao; Peter S N Rowe; Baocheng Hu; Ya Wang
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.